Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Revenue

In the year 2023, Neuren Pharmaceuticals had annual revenue of 231.93M AUD with 1,493.66% growth. Revenue in the quarter ending December 31, 2023 was 169.00M AUD with 5,186.17% year-over-year growth.

• Revenue: 231.93M
• Revenue Growth: +7,154.46%
• P/S Ratio: 10.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.54B AUD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	231.93M	217.37M	1,493.66%
Dec 31, 2022	14.55M	11.36M	355.21%
Dec 31, 2021	3.20M	2.48M	345.89%
Dec 31, 2020	717.00K	222.00K	44.85%
Dec 31, 2019	495.00K	-13.50M	-96.46%
Dec 31, 2018	13.99M	13.36M	2,117.12%
Dec 31, 2017	631.00K	-2.52M	-79.97%
Dec 31, 2016	3.15M	1.48M	88.28%
Dec 31, 2015	1.67M	-1.26M	-42.92%
Dec 31, 2014	2.93M	-1.86M	-38.86%
Dec 31, 2013	4.79M	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	4.65M	-355.15K	-7.10%
Dec 31, 2009	5.00M	2.73M	119.98%
Dec 31, 2008	2.27M	1.33M	140.89%
Dec 31, 2007	944.16K	771.19K	445.86%
Dec 31, 2006	172.97K	-256.70K	-59.74%
Dec 31, 2005	429.67K	-970.12K	-69.30%
Dec 31, 2004	1.40M	-1.44M	-50.64%
Dec 31, 2003	2.84M	714.42K	33.68%
Dec 31, 2002	2.12M	-	-